Related Experiment Video
Updated: May 17, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Diabetic HDL is dysfunctional in stimulating endothelial cell migration and proliferation due to down regulation of
1The Institute of Cardiovascular Sciences, Ministry of Education, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Peking University Health Science Center, Beijing, China.
Insights
Diabetic high-density lipoprotein (HDL) dysfunction impairs endothelial cell function due to reduced SR-BI receptor levels. This downregulation affects cell proliferation, migration, and chronic Akt activation.
Area of Science:
- Cardiovascular Biology
- Endocrinology
- Lipid Metabolism
Background:
- Diabetic high-density lipoprotein (HDL) exhibits reduced capacity to stimulate endothelial cell (EC) proliferation, migration, and adhesion.
- The underlying mechanisms of diabetic HDL dysfunction remain incompletely understood.
Purpose of the Study:
- To investigate the mechanistic features contributing to diabetic HDL dysfunction.
- To elucidate the role of the HDL receptor scavenger receptor class B type 1 (SR-BI) in diabetic HDL's effects on ECs.
Main Methods:
- Assessed the impact of normal and diabetic HDL on human umbilical vein endothelial cells (HUVECs) and mouse aortic endothelial cells (MAECs).
- Investigated the expression and function of SR-BI in ECs treated with different HDL types.
- Analyzed Akt phosphorylation in response to HDL treatment over time.
Main Results:
- Diabetic HDL-induced endothelial dysfunction was associated with decreased SR-BI protein levels.
- SR-BI downregulation significantly impaired the proliferative and migratory effects of normal HDL on MAECs.
- While both normal and diabetic HDL induced acute Akt phosphorylation, diabetic HDL showed reduced chronic Akt activation, linked to SR-BI downregulation.
Conclusions:
- Diabetic HDL dysfunction in promoting EC proliferation, migration, and adhesion is linked to SR-BI downregulation.
- Reduced SR-BI expression diminishes diabetic HDL's capacity for chronic Akt activation, contributing to endothelial dysfunction.
Background:
Diabetic HDL had diminished capacity to stimulate endothelial cell (EC) proliferation, migration, and adhesion to extracellular matrix. The mechanism of such dysfunction is poorly understood and we therefore sought to determine the mechanistic features of diabetic HDL dysfunction.
Methodology/Principal Findings:
We found that the dysfunction of diabetic HDL on human umbilical vein endothelial cells (HUVECs) was associated with the down regulation of the HDL receptor protein, SR-BI. Akt-phosphorylation in HUVECs was induced in a biphasic manner by normal HDL. While diabetic HDL induced Akt phosphorylation normally after 20 minutes, the phosphorylation observed 24 hours after diabetic HDL treatment was reduced. To determine the role of SR-BI down regulation on diminished EC responses of diabetic HDL, Mouse aortic endothelial cells (MAECs) were isolated from wild type and SR-BI (-/-) mice, and treated with normal and diabetic HDL. The proliferative and migratory effects of normal HDL on wild type MAECs were greatly diminished in SR-BI (-/-) cells. In contrast, response to diabetic HDL was impaired in both types suggesting diminished effectiveness of diabetic HDL on EC proliferation and migration might be due to the down regulation of SR-BI. Additionally, SR-BI down regulation diminishes diabetic HDL's capacity to activate Akt chronically.
Conclusions/Significance:
Diabetic HDL was dysfunctional in promoting EC proliferation, migration, and adhesion to matrix which was associated with the down-regulation of SR-BI. Additionally, SR-BI down regulation diminishes diabetic HDL's capacity to activate Akt chronically.
Related Concept Videos
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology
Regulation of Angiogenesis and Blood Supply
Type I Diabetes II: Pathophysiology
Insulin: The Receptor and Signaling Pathways